Table 3.
Measles-Rubella (MR) availability, doses administered, and doses wasted across each tailoring scenario of 10-dose and 1-dose MR vaccines.
| Scenario | Location | 10-dose MR vaccine availability |
10-dose MR total doses administered |
10-dose MR doses wasted |
10-dose MR open vial wastage |
1-dose MR vaccine availability |
1-dose MR - total doses administered |
1-dose MR doses wasted |
1-dose MR open vial wastage |
Total MR vaccine availability |
Total MR doses administered |
Total MR doses wasted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 dose MR all locations | Total | 77% (62%) | 937,512 (758,288) | 955,517 (194,728) | 50% (20%) | - | - | - | - | 77% (62%) | 937,512 (758,288) | 955,517 (194,728) |
| Rural districts | 92% (72%) | 672,475 (513,762) | 732,623 (147,776) | 53% (22%) | - | - | - | - | - | 672,475 (513,762) | 732,623 (147,776) | |
| Urban districts | 57% (52%) | 265,037 (244,526) | 222,894 (46,952) | 40% (16%) | - | - | - | - | - | 265,037 (244,526) | 222,894 (46,952) | |
| Rural HFs | 97% (62%) | 344,534 (219,159) | 454,293 (87,350) | 62% (28%) | - | - | - | - | - | 344,534 (219,159) | 454,293 (87,350) | |
| Urban HFs | 70% (64%) | 592,978 (539,129) | 501,223 (107,370) | 40% (16%) | - | - | - | - | - | 592,978 (539,129) | 501,223 (107,370) | |
| 1 dose MR all locations | Total | - | - | - | - | 74% | 904,616 | - | - | 74% (74%) | 904,616 | 0 |
| Rural districts | 90% | 667,293 | 667,293 | 0 | ||||||||
| Urban districts | - | - | - | - | 50% | 237,324 | - | - | - | 237,324 | 0 | |
| Rural HFs | - | - | - | - | 96% | 346,138 | - | - | - | 346,138 | 0 | |
| Urban HFs | - | - | - | - | 65% | 558,479 | - | - | - | 558,479 | 0 | |
| 1 dose MR rural districts; 10 dose urban districts | Total | 53% (49%) | 254,524 (234,381) | 172,379 (46,149) | 40% (16%) | 90% | 666,113 | - | - | 75% (74%) | 920,637 (900494) | 172,379 (46,149) |
| Rural districts | - | 0 | 0 | - | 90% | 666,113 | - | - | - | 666,113 (666,113) | 0 | |
| Urban DISTRICTS | 53% (49%) | 254,524 (234,381) | 172,379 (46,149) | 40% (16%) | 0% | 0 | - | - | - | 254,524 (234,381) | 172,379 (46,149) | |
| Rural HFs | 96% (65%) | 59,689 (40,343) | 83,597 (16,538) | 58% (29%) | 96% | 285,573 | - | - | - | 345,262 (325,916) | 83,597 (16,538) | |
| Urban HFs | 47% (47%) | 194,835 (194,038) | 88,782 (29,603) | 31% (13%) | 86% | 380,541 | - | - | - | 575,376 (574,579) | 88,782 (29,603) | |
| 1 dose MR rural HFs; 10 dose urban HFs | Total | 69% (62%) | 588,404 (535,820) | 394,377 (106,840) | 40% (17%) | 97% | 348,190 | - | - | 77% (72%) | 936,594 (884,010) | 394,377 (106,840) |
| Rural districts | 88%(77%) | 390,538 (340,635) | 304,374 (77,376) | 44% (19%) | 97% | 288,865 | - | - | - | 679,403 (629,500) | 304,374 (77,376) | |
| Urban districts | 48% (47%) | 197,866 (195,184) | 90,003 (29,456) | 31% (13%) | 96% | 59,325 | - | - | - | 257,191 (254,509) | 90,003 (29,456) | |
| Rural HFs | - | 0 | 0 | - | 97% | 348,190 | - | - | - | 348,190 (348,190) | 0 | |
| Urban HFs | 69% (62%) | 588,404 (535,820) | 394,377 (106,840) | 40% (17%) | - | 0 | - | - | - | 588,404 (535,820) | 394,377 (106,840) | |
| 1 dose MR outreach; 10 dose fixed | Total | 75% (52%) | 426,144 (297,562) | 629,135 (77,288) | 60% (21%) | 75% | 486,112 | - | - | 75% (64%) | 912,256 (783,674) | 629,135 (77,288) |
| Rural districts | 90% (57%) | 315,838 (200,442) | 527,645 (57,828) | 63% (22%) | 91% | 354,742 | - | - | - | 670,580 (555,184) | 527,645 (57,828) | |
| Urban districts | 50% (44%) | 110,306 (97,120) | 101,490 (19,460) | 48% (17%) | 51% | 131,369 | - | - | - | 241,675 (228,489) | 101,490 (19,460) | |
| Rural HFs | 96% (46%) | 161,556 (78,258) | 375,926 (27,573) | 70% (26%) | 96% | 184,700 | - | - | - | 346,256 (262,958) | 375,926 (27,573) | |
| Urban HFs | 66% (55%) | 264,588 (219,303) | 253,210 (49,707) | 49% (18%) | 66% | 301,411 | - | - | - | 565,999 (520,714) | 253,210 (49,707) |
*
MR = measles-rubella vaccine; HF = health facility.
**
Results presented in parentheses are when an MR vial is opened if at least half of the doses are used.